Emerald Advisers
Emerald Advisers reported 237 stocks worth $4.2B in its 13F filing for Q2 2026, filed Aug 5, 2026. Its largest holdings are TVTX (2.1%), CDNL (1.9%) and MRCY (1.8%). Compared with Q1 2026, the fund opened new positions in LGN, SXT and TEX, added to TVTX, CDNL and MRCY, trimmed KLIC, AGX and SMTC and sold out of BBIO, SPXC and SITM.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  TVTX Travere Therapeutics Inc | $90.9M | 2.1% | 1.6M | +44K (+3%) | 8 of 8 | |
| 2 |  CDNL Cardinal Infrastructure Grou | $79.9M | 1.9% | 848K | +269K (+47%) | 3 of 8 | |
| 3 |  MRCY Mercury Sys Inc | $78.1M | 1.8% | 639K | +43K (+7%) | 5 of 8 | |
| 4 |  AIR Aar Corp | $74.6M | 1.8% | 522K | +76K (+17%) | 8 of 8 | |
| 5 |  VSEC Vse Corp | $73.8M | 1.7% | 323K | +8,363 (+3%) | 6 of 8 | |
| 6 |  KLIC KULICKE & SOFFA INDS INC | $73.8M | 1.7% | 552K | −17K (−3%) | 8 of 8 | |
| 7 |  AGX Argan Inc | $71.3M | 1.7% | 89K | −5,976 (−6%) | 4 of 8 | |
| 8 |  CECO Ceco Environmental Corp | $66.9M | 1.6% | 737K | +214K (+41%) | 4 of 8 | |
| 9 |  CORT Corcept Therapeutics Inc | $65.1M | 1.5% | 748K | +543K (+264%) | 6 of 8 | |
| 10 |  LIVN Livanova PLC | $64.7M | 1.5% | 787K | +117K (+17%) | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 BBIO Bridgebio Pharma Inc | $38.3M | 515K |
 SPXC Spx Technologies Inc | $29.4M | 147K |
KALVISTA PHARMACEUTICALS INC | $25.4M | 1.3M |
 SITM Sitime Corp | $22.7M | 66K |
 IONQ Ionq Inc | $12.9M | 448K |
🔒 Free account: see all 30.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 5, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Emerald Advisers 13F FAQ
What does Emerald Advisers own?
Emerald Advisers reported 237 stocks worth $4.2B in its 13F filing for Q2 2026, filed Aug 5, 2026. Its largest holdings are TVTX (2.1%), CDNL (1.9%) and MRCY (1.8%). The table above lists every position in the filing (the top 10 without an account).
What did Emerald Advisers buy and sell in Q2 2026?
Compared with Q1 2026: 28 new positions, 80 added to, 82 trimmed and 39 sold out. New positions include LGN, SXT and TEX. It sold all of BBIO, SPXC and SITM.
When will Emerald Advisers file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Emerald Advisers's portfolio worth?
The Q2 2026 filing reports $4.2B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.